Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1)
- PMID: 21262968
- PMCID: PMC3060549
- DOI: 10.1074/jbc.M110.185983
Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1)
Abstract
Latent membrane protein 1 (LMP1), encoded by Epstein-Barr virus, is required for EBV-mediated B cell transformation and plays a significant role in the development of posttransplant B cell lymphomas. LMP1 has also been implicated in exacerbation of autoimmune diseases such as systemic lupus erythematosus. LMP1 is a constitutively active functional mimic of the tumor necrosis factor receptor superfamily member CD40, utilizing tumor necrosis factor receptor-associated factor (TRAF) adaptor proteins to induce signaling. However, LMP1-mediated B cell activation is amplified and sustained compared with CD40. We have previously shown that LMP1 and CD40 use TRAFs 1, 2, 3, and 5 differently. TRAF6 is important for CD40 signaling, but the role of TRAF6 in LMP1 signaling in B cells is not clear. Although TRAF6 binds directly to CD40, TRAF6 interaction with LMP1 in B cells has not been characterized. Here we tested the hypothesis that TRAF6 is a critical regulator of LMP1 signaling in B cells, either as part of a receptor-associated complex and/or as a cytoplasmic adaptor protein. Using TRAF6-deficient B cells, we determined that TRAF6 was critical for LMP1-mediated B cell activation. Although CD40-mediated TRAF6-dependent signaling does not require the TRAF6 receptor-binding domain, we found that LMP1 signaling required the presence of this domain. Furthermore, TRAF6 was recruited to the LMP1 signaling complex via the TRAF1/2/3/5 binding site within the cytoplasmic domain of LMP1.
Figures
References
-
- Pai S., Khanna R. (2001) Semin. Cancer Biol. 11, 455–460 - PubMed
-
- Küppers R. (2003) Nat. Rev. Immunol. 3, 801–812 - PubMed
-
- Busch L. K., Bishop G. A. (1999) J. Immunol. 162, 2555–2561 - PubMed
-
- Schubert S., Abdul-Khaliq H., Lehmkuhl H. B., Yegitbasi M., Reinke P., Kebelmann-Betzig C., Hauptmann K., Gross-Wieltsch U., Hetzer R., Berger F. (2009) Pediatr. Transplant 13, 54–62 - PubMed
-
- Schubert S., Renner C., Hammer M., Abdul-Khaliq H., Lehmkuhl H. B., Berger F., Hetzer R., Reinke P. (2008) J. Heart Lung Transplant. 27, 100–105 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
